Literature DB >> 27647871

Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.

Niharika Sharma-Chawla1,2, Vicky Sender3, Olivia Kershaw4, Achim D Gruber4, Julia Volckmar1, Birgitta Henriques-Normark3,5, Sabine Stegemann-Koniszewski6,2, Dunja Bruder6,2.   

Abstract

Influenza A virus (IAV) and Streptococcus pneumoniae are major causes of respiratory tract infections, particularly during coinfection. The synergism between these two pathogens is characterized by a complex network of dysregulated immune responses, some of which last until recovery following IAV infection. Despite the high serotype diversity of S. pneumoniae and the serotype replacement observed since the introduction of conjugate vaccines, little is known about pneumococcal strain dependency in the enhanced susceptibility to severe secondary S. pneumoniae infection following IAV infection. Thus, we studied how preinfection with IAV alters host susceptibility to different S. pneumoniae strains with various degrees of invasiveness using a highly invasive serotype 4 strain, an invasive serotype 7F strain, and a carrier serotype 19F strain. A murine model of pneumococcal coinfection during the acute phase of IAV infection showed a significantly increased degree of pneumonia and mortality for all tested pneumococcal strains at otherwise sublethal doses. The incidence and kinetics of systemic dissemination, however, remained bacterial strain dependent. Furthermore, we observed strain-specific alterations in the pulmonary levels of alveolar macrophages, neutrophils, and inflammatory mediators ultimately affecting immunopathology. During the recovery phase following IAV infection, bacterial growth in the lungs and systemic dissemination were enhanced in a strain-dependent manner. Altogether, this study shows that acute IAV infection predisposes the host to lethal S. pneumoniae infection irrespective of the pneumococcal serotype, while the long-lasting synergism between IAV and S. pneumoniae is bacterial strain dependent. These results hold implications for developing tailored therapeutic treatment regimens for dual infections during future IAV outbreaks.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27647871      PMCID: PMC5116722          DOI: 10.1128/IAI.00422-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  The innate immune rheostat: influence on lung inflammatory disease and secondary bacterial pneumonia.

Authors:  Tracy Hussell; Mary M Cavanagh
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

Review 2.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

3.  Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps.

Authors:  Florian Wartha; Katharina Beiter; Barbara Albiger; Jenny Fernebro; Arturo Zychlinsky; Staffan Normark; Birgitta Henriques-Normark
Journal:  Cell Microbiol       Date:  2007-01-09       Impact factor: 3.715

Review 4.  The role of influenza in the severity and transmission of respiratory bacterial disease.

Authors:  Michael J Mina; Keith P Klugman
Journal:  Lancet Respir Med       Date:  2014-08-15       Impact factor: 30.700

5.  Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen.

Authors:  K Sjöström; C Spindler; A Ortqvist; M Kalin; A Sandgren; S Kühlmann-Berenzon; B Henriques-Normark
Journal:  Clin Infect Dis       Date:  2006-01-17       Impact factor: 9.079

6.  Granzyme A impairs host defense during Streptococcus pneumoniae pneumonia.

Authors:  Florry E van den Boogaard; Klaas P J M van Gisbergen; Juanita H Vernooy; Jan P Medema; Joris J T H Roelofs; Marieke A D van Zoelen; Henrik Endeman; Douwe H Biesma; Louis Boon; Cornelis Van't Veer; Alex F de Vos; Tom van der Poll
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-24       Impact factor: 5.464

7.  Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae.

Authors:  C Blomberg; J Dagerhamn; S Dahlberg; S Browall; J Fernebro; B Albiger; E Morfeldt; S Normark; B Henriques-Normark
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

8.  Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice.

Authors:  Hazem E Ghoneim; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2013-11-23       Impact factor: 5.226

9.  The polysaccharide capsule of Streptococcus pneumonia partially impedes MyD88-mediated immunity during pneumonia in mice.

Authors:  Alex F de Vos; Mark C Dessing; Adriana J J Lammers; Alexander P N A de Porto; Sandrine Florquin; Onno J de Boer; Regina de Beer; Sanne Terpstra; Hester J Bootsma; Peter W Hermans; Cornelis van 't Veer; Tom van der Poll
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

10.  Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Authors:  Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more
  27 in total

Review 1.  Prostaglandin E2 as a Regulator of Immunity to Pathogens.

Authors:  Giovanny J Martínez-Colón; Bethany B Moore
Journal:  Pharmacol Ther       Date:  2017-12-22       Impact factor: 12.310

Review 2.  Trained immunity and host-pathogen interactions.

Authors:  Adeline Peignier; Dane Parker
Journal:  Cell Microbiol       Date:  2020-09-17       Impact factor: 3.715

3.  Double-Edged Role of Interleukin 17A in Streptococcus pneumoniae Pathogenesis During Influenza Virus Coinfection.

Authors:  Ganesh Ambigapathy; Taylor Schmit; Ram Kumar Mathur; Suba Nookala; Saad Bahri; Liise-Anne Pirofski; M Nadeem Khan
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

4.  Pneumococcal Phenotype and Interaction with Nontypeable Haemophilus influenzae as Determinants of Otitis Media Progression.

Authors:  Joseph A Lewnard; Noga Givon-Lavi; Paula A Tähtinen; Ron Dagan
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

5.  Hierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection.

Authors:  Stefanie Duvigneau; Niharika Sharma-Chawla; Alessandro Boianelli; Sabine Stegemann-Koniszewski; Van Kinh Nguyen; Dunja Bruder; Esteban A Hernandez-Vargas
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

Review 6.  Port d'Entrée for Respiratory Infections - Does the Influenza A Virus Pave the Way for Bacteria?

Authors:  Nikolai Siemens; Sonja Oehmcke-Hecht; Thomas C Mettenleiter; Bernd Kreikemeyer; Peter Valentin-Weigand; Sven Hammerschmidt
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

Review 7.  Secondary Bacterial Infections Associated with Influenza Pandemics.

Authors:  Denise E Morris; David W Cleary; Stuart C Clarke
Journal:  Front Microbiol       Date:  2017-06-23       Impact factor: 5.640

8.  Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection.

Authors:  Drishti Kaul; Raveen Rathnasinghe; Marcela Ferres; Gene S Tan; Aldo Barrera; Brett E Pickett; Barbara A Methe; Suman R Das; Isolda Budnik; Rebecca A Halpin; David Wentworth; Mirco Schmolke; Ignacio Mena; Randy A Albrecht; Indresh Singh; Karen E Nelson; Adolfo García-Sastre; Chris L Dupont; Rafael A Medina
Journal:  Nat Commun       Date:  2020-05-21       Impact factor: 14.919

9.  Effect of Vitamin A Deficiency in Dysregulating Immune Responses to Influenza Virus and Increasing Mortality Rates After Bacterial Coinfections.

Authors:  Rhiannon R Penkert; Amanda P Smith; Eike R Hrincius; Jonathan A McCullers; Peter Vogel; Amber M Smith; Julia L Hurwitz
Journal:  J Infect Dis       Date:  2021-05-28       Impact factor: 5.226

Review 10.  Altered Signal Transduction in the Immune Response to Influenza Virus and S. pneumoniae or S. aureus Co-Infections.

Authors:  Janine J Wilden; Jasmin C Jacob; Christina Ehrhardt; Stephan Ludwig; Yvonne Boergeling
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.